Ildong stock reflects a KRW 36.75 billion oncology deal
Published on 10/07/2026 at 04:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Ildong stock (KR7249420001) was trading at KRW 14,850 on the KOSPI on October 7, 2026, up 0.81 percent from the previous close. The company is strengthening its oncology strategy through a KRW 36.75 billion investment in Idience, a group cancer-drug developer.
Idience stake shifts pipeline strategy
According to CHOSUNBIZ on September 30, 2026, Ildong Pharmaceutical approved the purchase of 7,097,016 redeemable convertible preferred shares in Idience. The transaction gives Ildong a 13.95 percent stake and is intended to strengthen links across the company's drug pipeline.
The investment includes KRW 31.75 billion tied to Idience's Series A financing and about KRW 5.0 billion from its Series B financing. Idience is developing benadaparib, a PARP1 selective inhibitor, giving the deal a direct connection to Ildong's new-drug development strategy rather than a passive financial investment.
Q2 revenue rose 6.8 percent
According to ATS View, Ildong's second-quarter 2026 revenue reached KRW 147.9 billion, 6.8 percent above the year-earlier quarter. Operating profit was KRW 2.0 billion, equivalent to a 1.3 percent operating margin.
The comparison shows improving sales momentum alongside a modest profit contribution. First-quarter 2026 revenue was KRW 142.0 billion and operating profit was KRW 9.2 billion, so second-quarter sales increased sequentially while operating profit declined. For investors, the Idience transaction therefore adds pipeline exposure while current earnings remain the nearer financial measure.
KOSPI quote remains below yearly high
Ildong's October 7, 2026 intraday range was KRW 14,810 to KRW 15,130, with volume of 124,127 shares at the quoted time of 11:16 a.m. KST. The 52-week range was KRW 11,250 to KRW 45,050, placing the current quote KRW 30,200 below the yearly high and KRW 3,600 above the low.
Ildong stock was last at KRW 14,850 on the KOSPI on October 7, 2026 at 11:16 a.m. KST, while its market capitalization stood at KRW 467.9 billion.
Ildong stock facts
- Company: Ildong Pharmaceutical Co., Ltd.
- ISIN: KR7249420001
- Ticker: 249420
- Trading venue: KOSPI
- Price (as of October 7, 2026, 11:16 a.m. KST): KRW 14,850
- Market capitalization: KRW 467.9 billion (as of October 7, 2026)
- 52-week range: KRW 11,250-KRW 45,050 (as of October 7, 2026)
- Sector / Industry: Pharmaceuticals
- Index membership: KOSPI
